HPQ Silica Pharmaceutical Market Segmented By Grade I, Grade II HPQ, HPQ Powder and Crystal Silica, Fumed Silica, Silica Gel, Spherulised Fused Silica, Synthetic Silica Material in Fillers for Dental, Medical Devices, Pharmaceuticals and Nutraceuticals
Industry: Chemicals and Materials
Published Date: November-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 276
Report ID: PMRREP25132
High Purity Quartz is Quartz with 99.99%+ purity and is very rare. Mostly, naturally occurring quartz contains a varied range of impurities, among which contamination in the form of substantial elements. Thus, quartz with ultra-low content of these impurities commands a significantly higher price and is considered to be a High Purity Quartz. HPQ is used in a diverse range of special applications. The HPQ is commercially available in different grades, according to the level of purities.
On the other hand, Silica or Silicon dioxide, in its purest form, is used in different pharmaceutical applications. This high purity silica is commonly found in nature in the form of quartz & can be commercially extracted from different mining processes. The raw silica found & extracted through mining is processed further and can be used to synthesize different types of silica, such as crystal silica, fumed silica, silica gel, fused silica & synthetic silica.
Leading drug manufacturers are using silica for the formulation of excipients, which is driving the market for high purity silica products. Also, demand arises from quartz ware & glass manufacturers, which in turn, is driving the HPQ & silica for pharmaceutical market over the forecast period
The availability of very limited resources of quartz & development of substitutes for silica in the market may prove to be a challenge for the HPQ silica market as it deters the use of HPQ & silica for pharmaceutical applications. The HPQ & Silica for Pharmaceutical is expected to create incremental $ opportunity worth nearly 60,458 thsd US$ during the forecast period, while expanding at a CAGR of 6.3%.
There are many factors associated with the collective growth of the HPQ & Silica for Pharmaceutical market. HPQ & Silica are one of the most adopted materials in the pharmaceutical applications. Newly developed grades of dental specialty silica, which provide very high cleaning to abrasion ratio, are widely being accepted among consumers and their increasing consumption is expected to drive the global HPQ & Silica for Pharmaceutical market at a high CAGR over the forecast period. High purity quartz is gaining adoption and traction in the formulations of dental filler and artificial teeth in HPQ & Silica for Pharmaceutical market.
Properties, such as effective safeguarding against foreign particles and contaminants, are working in favor of HPQ in getting traction in HPQ & Silica for Pharmaceutical market. Upsurge in patients suffering from numerous dental diseases due to increase in consumption of alcohol and tobacco and increasing cases of dental cavities are also expected to create significant opportunities for the growth of high purity quartz.
On the other hand, increase in drug demand will lead to demand for value added materials for the formulation for excipients & nutraceuticals. Fumed Silica is turning over as the material of choice in excipient formulations in HPQ & Silica for Pharmaceutical market. Also, demand for glassware & quartz ware for storage purposes is expected to further give a boost to HPQ & Silica for Pharmaceutical market.
On the basis of type, the HPQ & Silica for Pharmaceutical market is expected to be dominated by the silica in which fumed silica is the most demanded sub-segment. Attributing to its ease of application, cost-effective nature and availability of advanced technological framework for the production of silica based products in HPQ & Silica for Pharmaceutical market will help synthetic silica to gain higher adoption in the commercial marketplace.
The silica type segment in the HPQ & Silica for pharmaceutical market is expected to grow at noteworthy CAGR & is expected to create significant incremental $ opportunity over the forecast period owing to its increased potential in HPQ & Silica for Pharmaceutical market.
However, the HPQ segment in HPQ & Silica for pharmaceutical market is expected to grow at a marginally low CAGR than silica during the forecast period with regular inflow of demand from pharmaceutical application. Despite registering marginal – low growth as compared to the silica type segment, HPQ is showing great potential in different pharmaceutical applications in HPQ & Silica for pharmaceutical market.
On the basis of application, HPQ is getting adopted in the formulations of glassware & quartz ware products used for storage purposes in HPQ & Silica for Pharmaceutical market. On the other hand, there is huge demand for silica for the formulations of nutraceuticals & pharmaceuticals in HPQ & Silica for Pharmaceutical market. These two applications will have a huge positive impact on the HPQ & Silica for Pharmaceutical market. The demand for nutraceuticals is expected to be generated from provinces & regions where people are suffering from numerous chronic disease. China & SEAP are the major regions where the prevalence of chronic diseases is quite high. The next prominent application of HPQ & Silca for Pharmaceutical Application is dental filler, which is growing at a noteworthy CAGR and is estimated to generate significant incremental $ opportunity.
From a regional perspective, China & Europe are projected to dominate the global HPQ & Silica for Pharmaceutical market throughout the forecast period. The manufacturing base in these regions can provide accommodations to a number of small & leading manufacturers who has its presence in HPQ & Silica for Pharmaceutical market.
China & Europe are the major suppliers or exporters of HPQ & Silica for Pharmaceutical to various nations globally. Jointly, these two areas entertain a market value share close to 55%. Of the various countries in SEAP, India is likely to witness highest growth with significant growth opportunities expected during the latter half of the forecast period in HPQ & Silica for Pharmaceutical market. On the other hand, LAMEA is projected to remain low volume – high growth regions in the global HPQ & Silica for Pharmaceutical market over the forecast period.
Some of the key players reported in this study on the HPQ & Silica for Pharmaceutical market include Unimin Corporation, The Quartz Corp, Russian Quartz LLC, Jiangsu Pacific Quartz Co., Ltd., Cabot Corporation, Evonik Industries AG, Wacker Chemie AG, Tokuyama Corporation and DowDuPont Inc.
| Attribute | Details |
|---|---|
|
Material Type |
|
|
Applications |
|
|
Region |
|
To know more about delivery timeline for this report Contact Sales
